Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

IPWatchdog Unleashed

IPWatchdog Unleashed artwork

The Price of Drug Innovation: Middlemen, Global Free-Riding and the Future of Medicine

Jul 28, 20251 hr 12 minAudio

Send us Fan Mail This week on IPWatchdog Unleashed we have a conversation about one of the hottest topics not just in the intellectual property world, but one of the topics that everyone both inside and outside of government is discussing. The cost of prescription pharmaceuticals is higher in the United States than anywhere else in the world, and many in the United States - including President Trump - are fed up with this imbalance. So, we will set the record straight and explain what is really causing Americans to pay high drug prices. To accomplish this my conversation is with Corey Salsberg, who is Vice President and Global Head of IP Affairs for Novartis, which is one of the leading and most innovative biopharmaceutical companies in the world. We discuss the issues that matter for the pharmaceutical industry, including what and who is really responsible for higher drug prices in America. We discuss President Trump’s attempts to force most favored nation (MFN) pricing that would demand the U.S. pay no more than what other countries pay for drugs. And we also take a moment to discuss the recent tragic deaths of Malcolm Jamal Warner, Ozzy Osbourne, and Hulk Hogan, and the future of artificial intelligence (AI). Visit us online at IPWatchdog.com. You can also visit our channels at YouTube, LinkedIn, X, Instagram and Facebook.

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. AI and Super-Fast Followers: Is the Patent Bargain Breaking Down?

    Nov 16, 20261 hrAudio

    Send us Fan Mail This week on IPWatchdog Unleashed, our host and the founder of IPWatchdog, Gene Quinn, speaks with Emily Johnson, Nicholas Lanzatella, Kwame Mensah, and Corey Salsberg. The panel explores how artificial...

    Credit the people on this episode

  2. Judge Newman’s Challenge: Don’t Just Navigate Patent Law—Change It

    Nov 13, 202611 minAudio

    Send us Fan Mail Uncertainty in patent rights undermines the investment needed to turn scientific breakthroughs into commercial products - but accepting that uncertainty is a choice. In this episode of IPWatchdog...

    Credit the people on this episode

  3. The Art of Patent Litigation: How to Make Your Case Compelling

    Nov 8, 20261 hr 4 minAudio

    Send us Fan Mail Effective patent litigation requires more than command of the law and technology. It demands an advocacy strategy tailored to the audience, the forum, and the business stakes. Recorded at IPWatchdog’s...

    Credit the people on this episode

  4. Is AI Use Putting Intellectual Property at Risk?

    Nov 2, 202655 minAudio

    Send us Fan Mail This week on IPWatchdog Unleashed, generative AI’s accelerating adoption raises a critical question: can organizations move quickly without compromising their intellectual property? Recorded at...

    Credit the people on this episode

  5. USPTO 101: The Risks of Subject Matter Eligibility Declarations

    Oct 26, 202659 minAudio

    Send us Fan Mail This week on IPWatchdog Unleashed, our host and the founder of IPWatchdog, Gene Quinn, speaks with John Rogitz and Clint Mehall. The conversation examines subject matter eligibility declarations, or...

    Credit the people on this episode